Richard H. NG, D.O.; Decision and Order, 29694-29696 [2012-12121]
Download as PDF
29694
Federal Register / Vol. 77, No. 97 / Friday, May 18, 2012 / Notices
laws of the state in which he does
business. See Scott Sandarg, D.M.D., 74
Fed. Reg. 17,528 (DEA 2009); David W.
Wang, M.D., 72 Fed. Reg. 54,297 (DEA
2007); Sheran Arden Yeates, M.D., 71
Fed. Reg. 39,130 (DEA 2006); Dominick
A. Ricci, M.D., 58 Fed. Reg. 51,104 (DEA
1993); Bobby Watts M.D., 53 Fed. Reg.
11,919 (DEA 1988).
Summary disposition in a DEA
revocation case is warranted even if the
period of suspension of a respondent’s
state medical license is temporary, or
even if there is the potential for
reinstatement of state authority because
‘‘revocation is also appropriate when a
state license had been suspended, but
with the possibility of future
reinstatement.’’ Stuart A. Bergman,
M.D., 70 Fed. Reg. 33,193 (DEA 2005);
Roger A. Rodriguez, M.D., 70 Fed. Reg.
33,206 (DEA 2005).
It is well-settled that when no
question of fact is involved, or when the
material facts are agreed upon, a
plenary, adversarial administrative
proceeding is not required, under the
rationale that Congress does not intend
administrative agencies to perform
meaningless tasks. See Layfe Robert
Anthony, M.D., 67 FR 35,582 (DEA
2002); Michael G. Dolin, M.D., 65 Fed.
Reg. 5661 (DEA 2000); see also Philip E.
Kirk, M.D., 48 Fed. Reg. 32,887 (DEA
1983), aff’d sub nom. Kirk v. Mullen,
749 F.2d 297 (6th Cir. 1984). Accord
Puerto Rico Aqueduct & Sewer Auth. v.
EPA, 35 F.3d 600, 605 (1st Cir. 1994).
In the instant case, the Government
asserts, and Respondent concedes, that
Respondent’s Indiana controlled
substance registration is suspended.
This allegation is confirmed by the
January 3, 2012 letter from the Board to
Respondent. I therefore find there is no
genuine dispute as to any material fact,
and that substantial evidence shows that
Respondent is presently without state
authority to handle controlled
substances in Illinois.
mstockstill on DSK4VPTVN1PROD with NOTICES
B. Respondent’s Right to Due Process
‘‘[W]here the state has revoked a
registrant’s license to handle controlled
substances, summary revocation of the
registrant’s DEA registration is only
appropriate if the registrant will be
afforded a state hearing on the merits of
the state revocation or suspension.’’
Schultz, 76 Fed. Reg. at 78,697; cf.
Odette Louise Campbell, M.D., No. 09–
62 (DEA May 11, 2010) (order
remanding for further proceedings
where it did not appear that state law
provided registrant with opportunity to
challenge merits of state suspension
based solely upon DEA immediate
suspension).
VerDate Mar<15>2010
18:21 May 17, 2012
Jkt 226001
In the present case, the Board
suspended Respondent’s state
controlled substance registration based
upon Ind. Code § 35–48–3–5(e), which
states:
(e) If the Drug Enforcement
Administration terminates, denies,
suspends or revokes a federal
registration for the manufacture,
distribution, or dispensing of controlled
substances, a registration issued by the
board under this chapter is
automatically suspended.
Section 35–48–3–5(f) further provides,
however, that ‘‘[t]he board may reinstate
a registration that has been suspended
under subsection (e), after a hearing, if
the board is satisfied that the applicant
is able to manufacture, distribute, or
dispense controlled substances with
reasonable skill and safety to the public
* * *.’’ Thus, Respondent is entitled to
a hearing to challenge the Board’s
automatic suspension of his state
controlled substance registration.
Furthermore, not only has Respondent
requested such a hearing, but he
concedes that the Board has confirmed
that he will be afforded such a hearing.
Because Respondent is afforded
adequate due process under state law,
and because ‘‘DEA does not have
statutory authority under the Controlled
Substances Act to maintain a
registration if the registrant is without
state authority to handle controlled
substances in the state in which he
practices,’’ Sheran Arden Yeates, M.D.,
71 Fed. Reg. 39,130, 39,131 (DEA 2006),
I conclude that summary disposition is
appropriate. See Kamal Tiwari, M.D., 76
Fed. Reg. 71,604 (DEA 2011) (summarily
revoking the respondents’ DEA
registrations for lack of state authority
where the state summarily suspended
the registrants’ state controlled
substance registrations based upon
DEA’s immediate suspension, noting
that the registrants ‘‘are entitled to a
hearing to challenge the underlying
allegations before the State board’’). It is
therefore
ORDERED that the hearing in this
case, scheduled to commence on
February 21, 2012, is hereby
CANCELLED; and it is further
ORDERED that all proceedings before
the undersigned are STAYED pending
the Agency’s issuance of a final order.
Recommended Decision
I grant the Government’s Motion for
Summary Disposition and recommend
that Respondent’s DEA COR BR9738595
be revoked and any pending
applications for renewal or modification
be denied.
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
Dated: January 27, 2012
Timothy D. Wing,
Administrative Law Judge.
[FR Doc. 2012–12119 Filed 5–17–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 12–19]
Richard H. NG, D.O.; Decision and
Order
On December 23, 2011,
Administrative Law Judge (ALJ)
Timothy D. Wing issued the attached
recommended decision. Neither party
filed exceptions to the decision. Having
reviewed the entire record, I have
decided to adopt the ALJ’s rulings,
findings of fact, conclusions of law, and
recommended Order.
To make clear, DEA’s longstanding
rule that a practitioner may not hold a
registration if he lacks authority under
state law to dispense controlled
substances and that the loss of such
authority subjects a practitioner’s
registration to revocation is not based
solely on 21 U.S.C. 824(a)(3), which is
a grant of authority to either suspend or
revoke a registration ‘‘upon a finding’’
that a registrant ‘‘has had his State
license or registration suspended,
revoked, or denied by competent State
authority and is no longer authorized by
State law to engage in the * * *
dispensing of controlled substances.’’
As explained in numerous cases, DEA’s
rule derives primarily from two other
provisions of the CSA, 21 U.S.C.
802(21), which defines the term
‘‘practitioner,’’ and 21 U.S.C. 823(f),
which sets forth the requirements for
obtaining a registration as a practitioner.
More specifically, the CSA defines
‘‘the term ‘practitioner’ [to] mean [] a
* * * physician * * * or other person
licensed, registered or otherwise
permitted, by * * * the jurisdiction in
which he practices * * * to distribute,
dispense, [or] administer * * * a
controlled substance in the course of
professional practice.’’ 21 U.S.C.
802(21). Consistent with this definition,
Congress, in setting the requirements for
obtaining a practitioner’s registration,
provided that ‘‘[t]he Attorney General
shall register practitioners * * * if the
applicant is authorized to dispense
* * * controlled substances under the
laws of the State in which he practices.’’
21 U.S.C. 823(f). Accordingly, because
one cannot obtain a practitioner’s
registration unless one holds authority
under state law to dispense controlled
substances, and because where a
E:\FR\FM\18MYN1.SGM
18MYN1
Federal Register / Vol. 77, No. 97 / Friday, May 18, 2012 / Notices
registered practitioner’s state authority
has been revoked or suspended, the
practitioner no longer meets the
statutory definition of a practitioner,
DEA has repeatedly held that the
possession of authority to dispense
controlled substances under the laws of
the State in which a practitioner engages
in professional practice is a
fundamental condition for both
obtaining and maintaining a
practitioner’s registration. See ALJ at 4
(citing cases).1 So too, ‘‘revocation is
warranted even where a practitioner’s
state authority has been summarily
suspended and the State has yet to
provide the practitioner with a hearing
to challenge the State’s action at which
he may ultimately prevail.’’ Kamal
Tiwari, M.D., 76 FR 71604, 71606
(2011); see also Bourne Pharmacy, Inc.,
72 FR 18273, 18274 (2007); Anne Lazar
Thorn, 62 FR 12847 (1997).
Accordingly, I adopt the ALJ’s
recommended order.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f) and 824(a), as well
as 28 CFR 0.100(b), I order that DEA
Certificate of Registration AN1255733,
issued to Richard H. Ng, D.O., be, and
it hereby is, revoked. I further order that
any pending application of Richard H.
Ng, D.O., to renew or modify his
registration, be, and it hereby is, denied.
This Order is effective immediately.2
Dated: May 4, 2012.
Michele M. Leonhart,
Administrator.
Jonathan P. Novak, Esq., for the
Government
Glen D. Crick, Esq., Lillian Walanka,
Esq.,
Michael D. Monico, Esq., Jacqueline
Jacobson, Esq., for the Respondent
mstockstill on DSK4VPTVN1PROD with NOTICES
Recommended Ruling, Findings of Fact,
Conclusions of Law and Decision of the
Administrative Law Judge
Timothy D. Wing, Administrative Law
Judge. This proceeding is an
adjudication governed by the
Administrative Procedure Act, 5 U.S.C.
551 et seq., to determine whether a
practitioner’s Certificate of Registration
(COR) with the Drug Enforcement
1 This citation is to the slip opinion as issued by
the ALJ.
2 The suspension order of the Illinois Department
of Financial and Professional Regulation found that
‘‘the public interest, safety and welfare imperatively
require emergency action’’ and that ‘‘Respondent’s
actions constitute an imminent danger to the
public.’’ Department of Fin. & Prof. Reg. v. Richard
H. Ng, D.O., No. 2011–08881 (Ill. Dep’t of Fin. &
Prof. Reg. Oct. 25, 2011) (order imposing temporary
suspension). Accordingly, I likewise conclude that
the public interest necessitates that this order be
effective immediately. See 21 CFR 1316.67.
VerDate Mar<15>2010
18:21 May 17, 2012
Jkt 226001
Administration (DEA, Government or
Agency) should be revoked. Without
this registration, Richard H. Ng, D.O.
(Respondent) would be unable to
lawfully possess, prescribe, dispense or
otherwise handle controlled substances.
I. Procedural Posture
On November 18, 2011, the Deputy
Assistant Administrator, DEA, issued an
Order to Show Cause (OSC) to
Respondent. The OCS provided notice
to Respondent of an opportunity to
show cause as to why the DEA should
not revoke Respondent’s DEA COR
AN1255733, pursuant to 21 U.S.C.
824(a)(3)-(4) and 823(f), alleging that
Respondent’s continued registration is
inconsistent with the public interest, as
that term is used in 21 U.S.C. 823(f), and
that Respondent’s medical license in the
State of Illinois has been suspended.
On December 20, 2011, I issued an
Order for Statements Addressing
Respondent’s State Authority and Order
for Prehearing Statements (Order).
On December 20, 2011, the
Government filed a Motion for
Summary Disposition. On December 21,
2011, I stayed the proceedings pending
resolution of the Government’s motion.
On December 22, 2011, Respondent
filed a Motion in Opposition to DEA’s
Motion for Summary Disposition.
II. The Parties’ Contentions
A. The Government
In support of its Motion for Summary
Disposition, the Government asserts that
on October 25, 2011, the Illinois
Department of Financial and
Professional Regulation (IDFPR)
executed an order summarily
suspending Respondent’s medical
license, effective immediately. (Gov’t
Mot. Summ. Disp. at 1.) The
Government contends that such state
authority is a necessary condition for
maintaining a DEA COR and, therefore,
asks that I grant its motion and forward
the matter to the Administrator.1 (Id. at
1–2.) In support of its motion, the
Government cites Agency precedent and
attaches the Notice of Temporary
1 The OSC provides Respondent with an
opportunity to show cause ‘‘as to why DEA should
not revoke’’ Respondent’s DEA COR. (OSC at 1.)
The OSC then factually alleges that Respondent’s
DEA COR ‘‘expired by its terms on October 31,
2011,’’ and that Respondent filed a timely request
to renew his registration. (Id.) The Government
requests that I ‘‘forward the matter to the
Administrator for a Final Order with a
recommendation that Respondent’s DEA
application for registration be denied.’’ (Gov’t Mot.
Summ. Disp. at 2.) For purposes of this
Recommended Decision, I will treat the
Government’s request as one to revoke
Respondent’s DEA COR and deny any pending
applications for renewal or modification.
PO 00000
Frm 00108
Fmt 4703
Sfmt 4703
29695
Suspension and Order entered by the
IDFPR as Exhibit A.
B. Respondent
Although Respondent concedes that
his ‘‘Illinois Controlled Substances
Registration is presently in suspended
status,’’ he argues that the suspension is
temporary in nature pending an
evidentiary hearing before the IDFPR.
(Resp’t Mot. in Opp’n at 1.) Respondent
notes that an evidentiary hearing will be
scheduled ‘‘in the very near future,’’ and
he believes that his license will be
restored to active status. (Id. at 1–2.) In
support of his motion, Respondent cites
Stuart A. Bergman, M.D., 70 Fed. Reg.
33,193 (DEA 2005), and argues that the
facts of this case similarly warrant a
delay in ruling on the Government’s
motion until after the conclusion of the
evidentiary hearing before the IDFPR.
(Id. at 2.)
III. Discussion
At issue is whether Respondent may
maintain his DEA COR given that
Illinois, the State in which Respondent
maintains his DEA COR, has suspended
Respondent’s Physician and Surgeon
License and Controlled Substance
License.
Under 21 U.S.C. 824(a)(3), a
practitioner’s loss of state authority to
engage in the practice of medicine and
to handle controlled substances is
grounds to revoke a practitioner’s
registration. Accordingly, this Agency
has consistently held that a person may
not hold a DEA registration if he is
without appropriate authority under the
laws of the state in which he does
business. See Scott Sandarg, D.M.D., 74
FR 17,528 (DEA 2009); David W. Wang,
M.D., 72 FR 54,297 (DEA 2007); Sheran
Arden Yeates, M.D., 71 FR 39,130 (DEA
2006); Dominick A. Ricci, M.D., 58 FR
51,104 (DEA 1993); Bobby Watts M.D.,
53 FR 11,919 (DEA 1988).
Summary disposition in a DEA
revocation case is warranted even if the
period of suspension of a respondent’s
state medical license is temporary, or
even if there is the potential for
reinstatement of state authority because
‘‘revocation is also appropriate when a
state license had been suspended, but
with the possibility of future
reinstatement.’’ Bergman, 70 FR at
33,193; Roger A. Rodriguez, M.D., 70 FR
33,206 (DEA 2005).
It is well-settled that when no
question of fact is involved, or when the
material facts are agreed upon, a
plenary, adversarial administrative
proceeding is not required, under the
rationale that Congress does not intend
administrative agencies to perform
meaningless tasks. See Layfe Robert
E:\FR\FM\18MYN1.SGM
18MYN1
29696
Federal Register / Vol. 77, No. 97 / Friday, May 18, 2012 / Notices
Anthony, M.D., 67 FR 35,582 (DEA
2002); Michael G. Dolin, M.D., 65 FR
5661 (DEA 2000); see also Philip E. Kirk,
M.D., 48 FR 32,887 (DEA 1983), aff’d
sub nom. Kirk v. Mullen, 749 F.2d 297
(6th Cir. 1984). Accord Puerto Rico
Aqueduct & Sewer Auth. v. EPA, 35
F.3d 600, 605 (1st Cir. 1994).
In the instant case, the Government
asserts, and Respondent concedes, that
Respondent’s Illinois license to practice
medicine and handle controlled
substances is suspended. This allegation
is confirmed by Government Exhibit A.
I therefore find there is no genuine
dispute as to any material fact, and that
substantial evidence shows that
Respondent is presently without state
authority to handle controlled
substances in Illinois. I decline to delay
ruling on the Government’s motion,
particularly in light of the fact that
Respondent does not appear to have a
scheduled hearing date before the
IDFPR. Compare Bergman, 70 FR at
33,193 (noting that the ALJ delayed
ruling on the Government’s motion
where the respondent had an
evidentiary hearing scheduled before
the state board). Because ‘‘DEA does not
have statutory authority under the
Controlled Substances Act to maintain a
registration if the registrant is without
state authority to handle controlled
substances in the state in which he
practices,’’ Sheran Arden Yeates, M.D.,
71 FR 39,130, 39,131 (DEA 2006), I
conclude that summary disposition is
appropriate. It is therefore
Ordered that the hearing in this case,
scheduled to commence on March 6,
2012, is hereby cancelled; and it is
further
Ordered that all proceedings before
the undersigned are stayed pending the
Agency’s issuance of a final order.
Recommended Decision
mstockstill on DSK4VPTVN1PROD with NOTICES
I grant the Government’s Motion for
Summary Disposition and recommend
that Respondent’s DEA COR
AN1255733 be revoked and any
pending applications for renewal or
modification be denied.2
Dated: December 23, 2011.
Timothy D. Wing,
Administrative Law Judge.
[FR Doc. 2012–12121 Filed 5–17–12; 8:45 am]
BILLING CODE 4410–09–P
2 Notably, Respondent requests that I recommend
the immediate suspension of his registration, rather
than revocation, citing 21 U.S.C. 824(a)(4). (Resp’t
Mot. in Opp’n at 3.)
VerDate Mar<15>2010
18:21 May 17, 2012
Jkt 226001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 12–30]
James Edgar Lundeen, Sr., M.D.;
Dismissal of Proceeding
On December 19, 2011, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to James Edgar Lundeen,
Sr., M.D. (Respondent), of Uniontown,
Ohio. The Order proposed the
revocation of Respondent’s DEA
Certificate of Registration as a
practitioner, and the denial of any
pending application to renew or modify
the registration, on the ground that
Respondent does not have authority
under Ohio law to practice medicine or
dispense controlled substances. Show
Cause Order at 1.
Following service of the Show Cause
Order, Respondent requested a hearing.
Thereafter, the Government moved for
summary disposition; Respondent
opposed the motion. On February 22,
2012, the ALJ granted the Government’s
motion, finding that there was no
dispute as to the material fact that
Respondent does not possess authority
under Ohio law to dispense controlled
substances and that he was therefore not
entitled to hold his DEA registration.
ALJ Dec. at 4–7. The ALJ thus
recommended that Respondent’s
registration be revoked and that any
pending application to renew or modify
his registration be denied. Id. at 8.
Neither party filed exceptions to the
ALJ’s decision and on March 20, 2012,
the ALJ forwarded the record to me for
Final Agency Action.
Upon review of the record, it was
noted that the Government had alleged
in the Show Cause Order that
Respondent’s registration was due to
expire on March 31, 2012. Show Cause
Order at 1. The record, however,
contained no evidence as to whether
Respondent had filed a renewal
application.1 Because in the absence of
a timely renewal application,
Respondent’s registration would expire,
see 5 U.S.C. 558(c), pursuant to 5 U.S.C.
556(e) and 21 CFR 1316.59, I have taken
official notice of Respondent’s
registration record with the Agency.2
1 Nor does the record contain a copy of
Respondent’s Registration or any other evidence
establishing the Agency’s jurisdiction. Henceforth,
the ALJs should ensure that such evidence is
submitted for the record prior to acting upon any
dispositive motion.
2 In accordance with the Administrative
Procedure Act (APA), an agency ‘‘may take official
notice of facts at any stage in a proceeding-even in
PO 00000
Frm 00109
Fmt 4703
Sfmt 4703
According to this record, Respondent
has not filed a renewal application.
Accordingly, I find that Respondent’s
registration has expired.
Under DEA precedent, ‘‘if a registrant
has not submitted a timely renewal
application prior to the expiration date,
then the registration expires and there is
nothing to revoke.’’ Ronald J. Riegel, 63
FR 67132, 67133 (1998); see also
Thomas E. Mitchell, 76 FR 20032, 20033
(2011). Moreover, in the absence of an
application (whether timely filed or
not), there is nothing to act upon.
Accordingly, because Respondent has
allowed his registration to expire and
has not filed any application, this case
is now moot and will be dismissed.3
Order
Pursuant to the authority vested in me
by 21 U.S.C. 824(a), as well as 28 CFR
0.100(b), I hereby order that the Order
to Show Cause issued to James Edgar
Lundeen, Sr., M.D., be, and it hereby is,
dismissed. This order is effective
immediately.
Dated: May 4, 2012.
Michele M. Leonhart,
Administrator.
[FR Doc. 2012–12118 Filed 5–17–12; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL SCIENCE FOUNDATION
Proposal Review Panel for Materials
Research; Notice of Meeting
In accordance with the Federal
Advisory Committee Act (Pub. L. 92–
463 as amended), the National Science
Foundation announces the following
meeting:
Name: Site visit review of the Materials
Research Science and Engineering Center
(MRSEC) at the University of Chicago by the
Division of Materials Research (DMR) #1203.
Dates & Times: June 6, 2012; 6:00 p.m.–
8:30 p.m.
June 7, 2012; 7:15 a.m.–8:30 p.m.
June 8, 2012; 7:15 a.m.–3:00 p.m.
Place: University of Chicago, Chicago, IL.
Type of Meeting: Part open.
the final decision.’’ U.S. Dept. of Justice, Attorney
General’s Manual on the Administrative Procedure
Act 80 (1947) (Wm. W. Gaunt & Sons, Inc., Reprint
1979). In accordance with the APA and DEA’s
regulations, Respondent is ‘‘entitled on timely
request to an opportunity to show to the contrary.’’
5 U.S.C. 556(e); see also 21 CFR 1316.59(e). To
allow Respondent the opportunity to refute the facts
of which I take official notice, Respondent may file
a motion for reconsideration within fifteen calendar
days of service of this order which shall commence
on the date this order is mailed.
3 While the Show Cause Order will be dismissed,
under 21 U.S.C. 823(f), Respondent is not entitled
to be registered until he is again ‘‘authorized to
dispense * * * controlled substances under the
laws of the State in which he practices.’’
E:\FR\FM\18MYN1.SGM
18MYN1
Agencies
[Federal Register Volume 77, Number 97 (Friday, May 18, 2012)]
[Notices]
[Pages 29694-29696]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12121]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 12-19]
Richard H. NG, D.O.; Decision and Order
On December 23, 2011, Administrative Law Judge (ALJ) Timothy D.
Wing issued the attached recommended decision. Neither party filed
exceptions to the decision. Having reviewed the entire record, I have
decided to adopt the ALJ's rulings, findings of fact, conclusions of
law, and recommended Order.
To make clear, DEA's longstanding rule that a practitioner may not
hold a registration if he lacks authority under state law to dispense
controlled substances and that the loss of such authority subjects a
practitioner's registration to revocation is not based solely on 21
U.S.C. 824(a)(3), which is a grant of authority to either suspend or
revoke a registration ``upon a finding'' that a registrant ``has had
his State license or registration suspended, revoked, or denied by
competent State authority and is no longer authorized by State law to
engage in the * * * dispensing of controlled substances.'' As explained
in numerous cases, DEA's rule derives primarily from two other
provisions of the CSA, 21 U.S.C. 802(21), which defines the term
``practitioner,'' and 21 U.S.C. 823(f), which sets forth the
requirements for obtaining a registration as a practitioner.
More specifically, the CSA defines ``the term `practitioner' [to]
mean [] a * * * physician * * * or other person licensed, registered or
otherwise permitted, by * * * the jurisdiction in which he practices *
* * to distribute, dispense, [or] administer * * * a controlled
substance in the course of professional practice.'' 21 U.S.C. 802(21).
Consistent with this definition, Congress, in setting the requirements
for obtaining a practitioner's registration, provided that ``[t]he
Attorney General shall register practitioners * * * if the applicant is
authorized to dispense * * * controlled substances under the laws of
the State in which he practices.'' 21 U.S.C. 823(f). Accordingly,
because one cannot obtain a practitioner's registration unless one
holds authority under state law to dispense controlled substances, and
because where a
[[Page 29695]]
registered practitioner's state authority has been revoked or
suspended, the practitioner no longer meets the statutory definition of
a practitioner, DEA has repeatedly held that the possession of
authority to dispense controlled substances under the laws of the State
in which a practitioner engages in professional practice is a
fundamental condition for both obtaining and maintaining a
practitioner's registration. See ALJ at 4 (citing cases).\1\ So too,
``revocation is warranted even where a practitioner's state authority
has been summarily suspended and the State has yet to provide the
practitioner with a hearing to challenge the State's action at which he
may ultimately prevail.'' Kamal Tiwari, M.D., 76 FR 71604, 71606
(2011); see also Bourne Pharmacy, Inc., 72 FR 18273, 18274 (2007); Anne
Lazar Thorn, 62 FR 12847 (1997). Accordingly, I adopt the ALJ's
recommended order.
---------------------------------------------------------------------------
\1\ This citation is to the slip opinion as issued by the ALJ.
---------------------------------------------------------------------------
Order
Pursuant to the authority vested in me by 21 U.S.C. 823(f) and
824(a), as well as 28 CFR 0.100(b), I order that DEA Certificate of
Registration AN1255733, issued to Richard H. Ng, D.O., be, and it
hereby is, revoked. I further order that any pending application of
Richard H. Ng, D.O., to renew or modify his registration, be, and it
hereby is, denied. This Order is effective immediately.\2\
---------------------------------------------------------------------------
\2\ The suspension order of the Illinois Department of Financial
and Professional Regulation found that ``the public interest, safety
and welfare imperatively require emergency action'' and that
``Respondent's actions constitute an imminent danger to the
public.'' Department of Fin. & Prof. Reg. v. Richard H. Ng, D.O.,
No. 2011-08881 (Ill. Dep't of Fin. & Prof. Reg. Oct. 25, 2011)
(order imposing temporary suspension). Accordingly, I likewise
conclude that the public interest necessitates that this order be
effective immediately. See 21 CFR 1316.67.
Dated: May 4, 2012.
Michele M. Leonhart,
Administrator.
Jonathan P. Novak, Esq., for the Government
Glen D. Crick, Esq., Lillian Walanka, Esq.,
Michael D. Monico, Esq., Jacqueline Jacobson, Esq., for the Respondent
Recommended Ruling, Findings of Fact, Conclusions of Law and Decision
of the Administrative Law Judge
Timothy D. Wing, Administrative Law Judge. This proceeding is an
adjudication governed by the Administrative Procedure Act, 5 U.S.C. 551
et seq., to determine whether a practitioner's Certificate of
Registration (COR) with the Drug Enforcement Administration (DEA,
Government or Agency) should be revoked. Without this registration,
Richard H. Ng, D.O. (Respondent) would be unable to lawfully possess,
prescribe, dispense or otherwise handle controlled substances.
I. Procedural Posture
On November 18, 2011, the Deputy Assistant Administrator, DEA,
issued an Order to Show Cause (OSC) to Respondent. The OCS provided
notice to Respondent of an opportunity to show cause as to why the DEA
should not revoke Respondent's DEA COR AN1255733, pursuant to 21 U.S.C.
824(a)(3)-(4) and 823(f), alleging that Respondent's continued
registration is inconsistent with the public interest, as that term is
used in 21 U.S.C. 823(f), and that Respondent's medical license in the
State of Illinois has been suspended.
On December 20, 2011, I issued an Order for Statements Addressing
Respondent's State Authority and Order for Prehearing Statements
(Order).
On December 20, 2011, the Government filed a Motion for Summary
Disposition. On December 21, 2011, I stayed the proceedings pending
resolution of the Government's motion. On December 22, 2011, Respondent
filed a Motion in Opposition to DEA's Motion for Summary Disposition.
II. The Parties' Contentions
A. The Government
In support of its Motion for Summary Disposition, the Government
asserts that on October 25, 2011, the Illinois Department of Financial
and Professional Regulation (IDFPR) executed an order summarily
suspending Respondent's medical license, effective immediately. (Gov't
Mot. Summ. Disp. at 1.) The Government contends that such state
authority is a necessary condition for maintaining a DEA COR and,
therefore, asks that I grant its motion and forward the matter to the
Administrator.\1\ (Id. at 1-2.) In support of its motion, the
Government cites Agency precedent and attaches the Notice of Temporary
Suspension and Order entered by the IDFPR as Exhibit A.
---------------------------------------------------------------------------
\1\ The OSC provides Respondent with an opportunity to show
cause ``as to why DEA should not revoke'' Respondent's DEA COR. (OSC
at 1.) The OSC then factually alleges that Respondent's DEA COR
``expired by its terms on October 31, 2011,'' and that Respondent
filed a timely request to renew his registration. (Id.) The
Government requests that I ``forward the matter to the Administrator
for a Final Order with a recommendation that Respondent's DEA
application for registration be denied.'' (Gov't Mot. Summ. Disp. at
2.) For purposes of this Recommended Decision, I will treat the
Government's request as one to revoke Respondent's DEA COR and deny
any pending applications for renewal or modification.
---------------------------------------------------------------------------
B. Respondent
Although Respondent concedes that his ``Illinois Controlled
Substances Registration is presently in suspended status,'' he argues
that the suspension is temporary in nature pending an evidentiary
hearing before the IDFPR. (Resp't Mot. in Opp'n at 1.) Respondent notes
that an evidentiary hearing will be scheduled ``in the very near
future,'' and he believes that his license will be restored to active
status. (Id. at 1-2.) In support of his motion, Respondent cites Stuart
A. Bergman, M.D., 70 Fed. Reg. 33,193 (DEA 2005), and argues that the
facts of this case similarly warrant a delay in ruling on the
Government's motion until after the conclusion of the evidentiary
hearing before the IDFPR. (Id. at 2.)
III. Discussion
At issue is whether Respondent may maintain his DEA COR given that
Illinois, the State in which Respondent maintains his DEA COR, has
suspended Respondent's Physician and Surgeon License and Controlled
Substance License.
Under 21 U.S.C. 824(a)(3), a practitioner's loss of state authority
to engage in the practice of medicine and to handle controlled
substances is grounds to revoke a practitioner's registration.
Accordingly, this Agency has consistently held that a person may not
hold a DEA registration if he is without appropriate authority under
the laws of the state in which he does business. See Scott Sandarg,
D.M.D., 74 FR 17,528 (DEA 2009); David W. Wang, M.D., 72 FR 54,297 (DEA
2007); Sheran Arden Yeates, M.D., 71 FR 39,130 (DEA 2006); Dominick A.
Ricci, M.D., 58 FR 51,104 (DEA 1993); Bobby Watts M.D., 53 FR 11,919
(DEA 1988).
Summary disposition in a DEA revocation case is warranted even if
the period of suspension of a respondent's state medical license is
temporary, or even if there is the potential for reinstatement of state
authority because ``revocation is also appropriate when a state license
had been suspended, but with the possibility of future reinstatement.''
Bergman, 70 FR at 33,193; Roger A. Rodriguez, M.D., 70 FR 33,206 (DEA
2005).
It is well-settled that when no question of fact is involved, or
when the material facts are agreed upon, a plenary, adversarial
administrative proceeding is not required, under the rationale that
Congress does not intend administrative agencies to perform meaningless
tasks. See Layfe Robert
[[Page 29696]]
Anthony, M.D., 67 FR 35,582 (DEA 2002); Michael G. Dolin, M.D., 65 FR
5661 (DEA 2000); see also Philip E. Kirk, M.D., 48 FR 32,887 (DEA
1983), aff'd sub nom. Kirk v. Mullen, 749 F.2d 297 (6th Cir. 1984).
Accord Puerto Rico Aqueduct & Sewer Auth. v. EPA, 35 F.3d 600, 605 (1st
Cir. 1994).
In the instant case, the Government asserts, and Respondent
concedes, that Respondent's Illinois license to practice medicine and
handle controlled substances is suspended. This allegation is confirmed
by Government Exhibit A. I therefore find there is no genuine dispute
as to any material fact, and that substantial evidence shows that
Respondent is presently without state authority to handle controlled
substances in Illinois. I decline to delay ruling on the Government's
motion, particularly in light of the fact that Respondent does not
appear to have a scheduled hearing date before the IDFPR. Compare
Bergman, 70 FR at 33,193 (noting that the ALJ delayed ruling on the
Government's motion where the respondent had an evidentiary hearing
scheduled before the state board). Because ``DEA does not have
statutory authority under the Controlled Substances Act to maintain a
registration if the registrant is without state authority to handle
controlled substances in the state in which he practices,'' Sheran
Arden Yeates, M.D., 71 FR 39,130, 39,131 (DEA 2006), I conclude that
summary disposition is appropriate. It is therefore
Ordered that the hearing in this case, scheduled to commence on
March 6, 2012, is hereby cancelled; and it is further
Ordered that all proceedings before the undersigned are stayed
pending the Agency's issuance of a final order.
Recommended Decision
I grant the Government's Motion for Summary Disposition and
recommend that Respondent's DEA COR AN1255733 be revoked and any
pending applications for renewal or modification be denied.\2\
---------------------------------------------------------------------------
\2\ Notably, Respondent requests that I recommend the immediate
suspension of his registration, rather than revocation, citing 21
U.S.C. 824(a)(4). (Resp't Mot. in Opp'n at 3.)
Dated: December 23, 2011.
Timothy D. Wing,
Administrative Law Judge.
[FR Doc. 2012-12121 Filed 5-17-12; 8:45 am]
BILLING CODE 4410-09-P